The North American Medical Marijuana Index is a market capitalization weighted subset of the growing universe of medical marijuana companies being listed on North American exchanges – currently more than 200 publicly traded companies.
For a security to be eligible for the Index:
•The issuer will generally have a market capitalization of greater than $75 million CAD
•The average monthly daily trading volume will generally be greater than 75,000 shares a day, with a trading value generally greater than $250,000
•The issuer will represent no more than 10% of the Index on each rebalance date
•The North American Medical Marijuana Index is initially expected to include 16 different companies
Rebalancing:
•Stocks in the Index are rebalanced quarterly on a market-capitalization basis, and capped so that no single stock can exceed 10% of the weight of the Index when rebalanced. Given the relatively high growth of the companies in the universe of marijuana-related stocks, as well as the fact that there could be relatively high degree of consolidation and acquisition in the industry, it’s important to have a relatively frequent rebalancing schedule.
Horizons ETFs is a member of Mirae Asset Global Investments. Commissions, management fees, expenses and applicable sales taxes all may be associated with an investment in the Horizons Medical Marijuana Life Sciences ETF managed by Horizons ETFs Management (Canada) Inc. (the “ETF”). The ETF is not guaranteed, its value changes frequently and past performance may not be repeated. The Prospectus contains important detailed information about the ETF. Please read the Prospectus before investing. Solactive is a trade name of Solactive AG (“Solactive”) and has been licensed for use by Horizons. The ETF is not sponsored, endorsed, sold or promoted by Solactive and Solactive makes no representation regarding the advisability of investing in the ETF.
31